Welcome!

News Feed Item

World's Best Analytics Teams Compete for INFORMS Franz Edelman Prize

CATONSVILLE, Md., Dec. 17, 2013 /PRNewswire-USNewswire/ -- The Institute for Operations Research and the Management Sciences (INFORMS®) proudly announces the six finalist organizations that will compete for the 2014 INFORMS Franz Edelman Prize. The Prize is the world's most prestigious recognition for excellence in applying advanced analytics to benefit business and humanitarian outcomes. 

This year's finalists are:

  1. Twitter, with Stanford University, for "The 'Who to Follow' System at Twitter: Strategy, Algorithms, and Revenue Impact."
  2. The U.S. Centers for Disease Control and Prevention (CDC), with Kid Risk, Inc., for "Using Integrated Analytical Models to Support Global Health Policies to Manage Vaccine Preventable Diseases: Polio Eradication and Beyond."
  3. The Energy Authority for "Hydroelectric Generation and Water Routing Optimizer."
  4. Grady Memorial Hospital, with the Georgia Institute of Technology, for "Modeling and Optimizing Emergency Department Workflow."
  5. Kidney Exchange at the Alliance for Paired Donation, with Stanford and MIT, for "Kidney Exchange."
  6. NBN Company, with Biari, for "Fiber Optic Network Optimization at NBN Co."

Now in its 43rd year, the INFORMS Franz Edelman Prize competition recognizes outstanding examples of analytics and operations research projects that transform companies, entire industries and people's lives. Using innovative advanced analytical methods, the teams were instrumental in helping their respective institutions make better decisions, providing a disciplined way by which management can improve organizational performance in a wide variety of situations and across both public and private organizations.  

INFORMS Franz Edelman finalist teams have contributed over $200 billion in benefits to business and the public interest. The 2014 INFORMS Franz Edelman Prize finalists were chosen after a rigorous review by accomplished verifiers, all of whom have led successful analytics projects. The verifiers come from IBM, BNSF, Bank of America, Verizon Wireless, HP, Eastman Chemical, Columbia University, Carnegie Mellon University, University of Chicago, the University of Chile, and other noted organizations. Finalists are chosen on the merits of how analytics methodologies were applied to solve problems, reduce costs, or otherwise improve results in real-world environments. The 2014 Edelman Prize winner will be announced at the Edelman Gala on March 31 during the INFORMS Conference on Business Analytics & Operations Research in Boston.  The winner will receive a $10,000 honorarium.

Past winners of the INFORMS Franz Edelman Prize include HP; the Dutch Delta Program Commissioner; MISO, the Midwest energy group; and Memorial Sloan-Kettering Cancer Center.

Additional information about the INFORMS Franz Edelman Prize and Competition, including video interviews with 2013 finalist executives, can be found online at https://www.informs.org/Recognize-Excellence/Franz-Edelman-Award.

About INFORMS
INFORMS is the leading international association for professionals in analytics and operations research (O.R.). INFORMS advances research, and develops and promotes best practices in analytics and O.R. through collaboration, knowledge sharing, and professional development. INFORMS helps business, government, and other organization professionals make better decisions to drive value to their organizations and society. Our certification program (CAP®), highly cited publications, educational meetings and conferences, continuing education, industry and process focused networking communities, competitions, and recognition provide professionals with the knowledge and connections they need to achieve ever greater value for their organizations. Further information about INFORMS can be found online at www.informs.org or @informs.

SOURCE INFORMS

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.